A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis.

Chin Med J (Engl) · 2023 · PMC10106172 · PMID 36805548

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a mild trendno p-value reported

There was a mild trend toward a smaller decrease in percentage of predicted FVC in the NBP group than in the placebo group.

also in 65 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.